Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

CORRECTING and REPLACING Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine

03:20 EST 1 Jan 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Biotechnology company leverages similarities between pregnancy and cancer in development of unique cancer immunotherapy treatment Please replace the release with the following corrected version due to multiple revisions. ...

Other Sources for this Article

Vaxenta Biotechnologies
Boris Markosian, CEO, 818-823–3632
Fax: 858-227–9774
Email: bmarkosi@vaxenta.com

NEXT ARTICLE

More From BioPortfolio on "CORRECTING and REPLACING Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine"

Search BioPortfolio:
Advertisement

Relevant Topics

Women's Health
Latest News Clinical Trials Research Drugs Reports Corporate
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Advertisement

Searches Linking to this Story